Latest Headlines

Latest Headlines

Bayer commits $700M to boost manufacturing for new hemophilia drugs

Bayer is gambling $700 million on the ultimate success of its new hemophilia drugs now in Phase III testing. That's about how much Bayer's growing healthcare division plans to spend as it boosts its manufacturing capacity at two sites in Germany.

Novartis's new Basel campus reflects Vasella's (now out-of-fashion) style

The careful, buttoned-down style favored by Novartis' top execs in Basel has been getting a makeover--at least on the architectural front.

BMS joins Merck with plans to whack plants in Ireland

Ireland's liberal tax code continues to attract drugmakers, but some of the long-term players are cutting back on their extensive manufacturing there. Bristol-Myers Squibb, with plans to lay off about 160 workers at two facilities, can now be added to that list.

GSK shares grant to help U.K. on how to rebuild its drug manufacturing base

GlaxoSmithKline, which is making big investments in manufacturing in the U.K., will help its homeland try to figure out how to revive its manufacturing base.

Word of a $16M Coloplast vaginal-mesh settlement spurs global resolution talk

Danish medical device maker Coloplast is said to have paid $16 million to settle lawsuits claiming it injured women with vaginal-mesh inserts. With settlement talk swirling around at least 5 more makers of the plagued devices, that has some watchers saying the time may be ripe for a global settlement.

Boston Scientific partners up to push Parkinson's tech in Europe

Neuromodulation devices have been key to Boston Scientific's years-long effort to reverse its lagging fortunes, and now the med tech giant has teamed up with two European nonprofits to promote its treatments for Parkinson's disease and dystonia.

J&J's Cordis won a CE mark for its renal denervation device

Johnson & Johnson is moving ahead with its renal denervation program in the wake of Medtronic's major setback, winning CE marking for its Renlane renal denervation system, which doctors in Europe are already using to treat drug-resistant hypertension.

EU breathes hope into GlaxoSmithKline's latest respiratory contender

A European Medicines Agency committee has recommended approval for another COPD treatment from GlaxoSmithKline, setting the stage for a likely nod in the coming months as the drugmaker looks to bolster its respiratory franchise.

Biogen Idec hits its first price hurdle for Tecfidera in the EU

Biogen Idec's hot-selling multiple sclerosis drug Tecfidera has to win reimbursement in individual European countries where governments have gotten stingy about parting with healthcare dollars. A decision Thursday by U.K. price watchdog NICE is an indication of the cost hurdles to be faced.

Medtronic unveils a new treatment for peripheral artery disease in Europe

Medtronic launched a new crossing catheter in Europe to treat peripheral artery disease. The device recently received a European CE mark, but has yet to win FDA clearance, the company said in a statement.